Skip to content

Vesugen

Synthetic tripeptide vascular bioregulator. Promotes endothelial cell renewal, improves vascular function, supports cardiovascular health. Sequence: Lys-Glu-Asp.

Intelligence Profile

Clinical Applications

Based on the available research literature, Vesugen (peptide KED) has been investigated primarily in laboratory studies for several potential therapeutic applications, though no completed clinical trials were identified in our search.

Investigated Applications

Neurological Conditions
The most substantial research focus has been on neurological applications, particularly for Alzheimer's disease and age-related neuronal changes. Studies have examined Vesugen's effects on neurogenesis regulation and protection of neurons from age-related deterioration. Research has also investigated its influence on neuronal differentiation of stem cells, suggesting potential applications in neurodegenerative conditions.

Aging and Cellular Protection
Multiple studies have explored Vesugen's role as a potential geroprotective agent. Research has examined its effects on:

  • Fibroblast function during cellular aging
  • Gene expression modulation in aging mesenchymal stem cell cultures
  • General anti-aging mechanisms at the cellular level

Cardiovascular Applications
Limited research has investigated Vesugen's vasoprotective properties, particularly in the context of atherosclerosis and restenosis prevention.

Cancer Research
Some preliminary investigation has examined effects on cell proliferation, including studies on leukemia cell lines.

Research Limitations

Important Note: The evidence base consists entirely of preclinical laboratory studies. No completed human clinical trials were identified, which significantly limits our understanding of Vesugen's clinical efficacy, optimal dosing, safety profile, or real-world therapeutic applications in patients.

The available studies are primarily mechanistic investigations conducted in cell cultures and animal models. While these provide insight into potential biological mechanisms, they cannot establish clinical effectiveness or safety in human patients.

Disclaimer: This information is for educational purposes only and should not be considered medical advice. Consult with qualified healthcare professionals before considering any experimental treatments.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.